AKT1 and cancer: HIF‐1 signaling can be inhibited indirectly or indirectly; for example, PI3K/Akt/mTOR signaling pathway can control the expression of HIF‐1a, and by inhibiting this pathway, HIF‐1 α expression is downregulated, increasing MDR cells' sensitivity to cancer treatments.263